EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms

Dong Chen iD, Olga K Weinberg iD

International Journal of Laboratory Hematology · 2023

DOI: 10.1111/ijlh.14184 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Dong Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Blast Crisis, Myeloproliferative Disorders. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasm (MPN‐BP) represents the final stage of the disease, which is complicated by complex genomic alterations. These alterations result from sequence changes in genetic material (DNA, RNA) and can lead to either a gain or loss of function of encoded proteins, such as adaptor proteins, enzymes, components of spliceosomes, cell cycle checkpoints regulators, transcription factors, or proteins in cell signaling pathways. Interference at various levels, including transcription, translation, and post‐translational modification (such as methylation, dephosphorylation, or acetylation), can contribute to these alterations. Mutated genes such as ASXL1, EZH2, IDH1, IDH2, TET2, SRSF2, U2AF1, TP53, NRAS, KRAS, PTPN11, SH2B3/LNK , and RUNX1 play active roles at different stages of genetic material expression, modification, and protein function manipulation in MPNs. These mutations are also correlated with, and can contribute to, the progression of MPN‐BP. In this review, we summarize their common mutational profiles, functions, and associations with progression of MPN‐BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blast CrisisMyeloproliferative DisordersHumansMutationGenomics

Stichwörter der Autor:innen

ASXL1EZH2IDH1IDH2KRASNRASPTPN11RUNX1SH2B3/LNKSRSF2TET2TP53U2AF1blast phase of myeloproliferative neoplasm

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, USA.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Dong Chen, Olga K Weinberg

Zitieren

APA

Chen, D., & Weinberg, O. K. (2023). Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14184

Vancouver

Chen D, Weinberg OK. Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14184

BibTeX
@article{Chen2023,
  author = {Chen, Dong and Weinberg, Olga K},
  title = {Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  doi = {10.1111/ijlh.14184}
}
Kostenlos starten →